Skip to content
OpenCapital
Get started

Novanta NOVT Automation Enabling Technologies — Research And Development Expense

Other segment segments

Medical Solutions
$14.25M+2.1%

Similar metrics at other companies

Hexcel logo
HXLEngineered Products — Research And Development Expense
$1.5M+36.4%
AeroVironment logo
AVAVAutonomous Systems — Research And Development Expense
$24.14M+7.3%
Resideo Technologies, Inc. logo
REZIProducts and Solutions — Research and development expenses
$36M+33.3%
TE Connectivity logo
TELResearch And Development And Engineering Expense
$237M+16.7%
TE Connectivity logo
TELTransportation Solutions — Research And Development And Engineering Expense
$121M+9.0%
Viasat logo
VSATDefense And Advanced Technologies — Research And Development Expense
$15.9M-8.1%

Other financials

Income statement

See full
Revenue$257.7M+10.4%
Gross profit$113.6M+8.8%
Operating income$27.5M-15.1%
Net income$21.1M-0.5%
EPS (diluted)$0.51-13.6%

Balance sheet

See full
Cash & equivalents$388.8M+267%
Total debt$291.3M-34.2%
Total equity$1.3B+70.3%
Total assets$1.8B+29.9%

Cash flow

See full
Operating cash flow$51.6M+62.9%
CapEx$4.1M-3.4%
Free cash flow$47.5M+73.2%

Valuation

See full
Market cap$5.53B-8.3%

Profitability

See full
Gross margin44.2%-0.5pp
Operating margin8.9%-3.5pp
Net margin5.3%-2.1pp
FCF margin6.8%-8.1pp

Returns & leverage

See full
Return on equity5.2%-4.6pp
Debt / equity0.2×-0.4×
Current ratio3.6×+1.0×

Where this comes from

Reported directly by Novanta in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Novanta’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Novanta's automation enabling technologies — research and development expense.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Novanta's automation enabling technologies — research and development expense?
Novanta (NOVT) reported automation enabling technologies — research and development expense of $9.03M in Q1 2026.
How has Novanta's automation enabling technologies — research and development expense changed year-over-year?
Novanta's automation enabling technologies — research and development expense decreased by 4.3% year-over-year, from $9.44M to $9.03M.
What is the long-term trend for Novanta's automation enabling technologies — research and development expense?
Over 3 years (2022 to 2025), Novanta's automation enabling technologies — research and development expense has grown at a -6.0% compound annual growth rate (CAGR), from $45.44M to $37.8M.
What does automation enabling technologies — research and development expense mean?
Costs incurred by the Automation Enabling Technologies segment for the discovery and development of new products, technologies, or processes. This investment is critical for maintaining long-term competitive advantage and innovation within the automation sector.